immun
nake
gene
dnaimmun
perspect
modern
approach
prophylact
well
therapeut
vaccin
pathogen
well
cancer
allergi
panel
dna
immunogen
develop
alreadi
clinic
trial
howev
immunogen
dna
vaccin
specif
appli
human
need
consider
improv
sever
approach
increas
dna
vaccin
immunogen
one
approach
impli
modif
encod
immunogen
chang
process
present
thu
overal
pattern
antiimmunogen
respons
eukaryot
express
vector
construct
encod
chimer
protein
compos
immunogen
special
target
signal
se
ornithin
decarboxylas
rt
revers
transcriptas
crt
ca
bind
protein
calreticulin
human
papilloma
viru
lysosomeassoci
protein
sarsn
nucleocapsid
sar
coronaviru
protein
lcmv
lymphocyt
choriomening
viru
mhc
major
histocompat
complex
class
mhc
ii
major
histocompat
complex
class
ii
one
promis
vaccin
type
today
dnavaccin
simplest
form
dnavaccin
plasmid
contain
gene
pathogen
protein
element
need
transcrib
gene
mammalian
cell
dna
introduc
mammalian
cell
immun
transcrib
encod
antigen
synthes
initi
immun
respons
fig
unlik
proteinbas
vaccin
dnavaccin
base
microbi
gene
tumor
antigen
advantag
synthes
specif
antigen
host
organ
process
correctli
induc
immun
respons
desir
specif
approach
promis
simplic
low
cost
product
transport
dnavaccin
compar
tradit
vaccin
moreov
gene
engin
allow
easi
modif
dnaimmunogen
new
antigen
design
properti
predict
silico
studi
use
dnavaccin
caus
anxieti
possibl
genet
materi
get
insert
host
genom
insert
mutagenesi
howev
probabl
event
extrem
low
rang
around
insert
per
nuclei
lower
rate
natur
insert
mutat
factor
dnavaccin
use
induc
protect
immun
respons
variou
infect
small
anim
rodent
larger
speci
seri
trial
prophylact
therapeut
dnavaccin
variou
human
pathogen
includ
hcv
perform
howev
immunogen
genet
vaccin
need
improv
especi
human
applic
variou
approach
use
order
increas
effici
dnavaccin
includ
develop
novel
method
dnavaccin
administr
electropor
becom
increasingli
popular
recent
year
supplement
vaccin
formul
cytokin
andor
chemokin
gene
optim
plasmid
vector
select
effect
gene
promot
regulatori
element
modul
plasmid
cpg
content
dnaimmunogen
also
modifi
code
sequenc
immunogen
often
chang
increas
express
one
promis
approach
modifi
immunogen
alter
process
present
pathway
redirect
achiev
label
protein
special
signal
sequenc
review
focus
signal
direct
protein
variou
cellular
compart
use
dnavaccin
design
order
recogn
immun
system
antigen
must
process
present
surfac
cell
molecul
major
histocompat
complex
mhc
two
main
class
molecul
mhc
class
mhci
mhc
class
ii
mhcii
order
bind
molecul
either
class
protein
encod
dnaimmunogen
must
go
antigen
process
special
cell
compart
tabl
endogen
protein
degrad
proteasom
present
complex
cell
surfac
recogn
receptor
cytotox
tcell
ctl
initi
cytotox
immun
respons
exogen
protein
hydrolyz
proteas
lysosom
antigen
fragment
gener
process
bound
mhcii
molecul
recogn
thelper
cell
facilit
cellular
well
humor
respons
thu
evid
process
pathway
immunogen
determin
type
immun
respons
induc
mention
earlier
process
antigen
via
mhci
pathway
result
ctlrespons
process
involv
sever
step
fig
protein
synthes
cell
broken
small
peptid
proteasom
fragment
taken
transporterprotein
associ
antigen
process
tap
protein
guid
peptid
endoplasm
reticulum
er
bind
mhci
molecul
peptidemhci
complex
transport
cell
surfac
recogn
tcell
ctl
manifest
initi
cellular
respons
increas
amount
protein
transport
proteasom
er
principl
increas
present
via
mhci
pathway
henc
avail
cell
surfac
result
enhanc
cellular
respons
degrad
proteasom
protein
must
bear
specif
signal
chain
ubiquitin
molecul
ub
small
polypeptid
consist
amino
acid
residu
eukaryot
cell
special
group
enzym
recogn
protein
substrat
coval
attach
polyubiquitin
substrat
enzymat
group
call
ubiquitinconjug
system
system
recogn
variou
proteasom
degrad
signal
signal
repres
specif
amino
acid
sequenc
specif
pattern
protein
phosphoryl
alter
protein
structur
often
missfold
sever
degrad
signal
characterist
amino
acid
sequenc
describ
first
signal
discov
ndegron
specif
first
amino
acid
residu
protein
serv
substrat
complex
cellular
enzym
respons
label
protein
polyubiquitin
chain
amino
acid
differ
capac
recogn
ubiquitin
enzym
tabl
also
degrad
signal
pestsequ
destruct
box
often
found
shortliv
cellular
protein
tabl
natur
first
amino
acid
residu
protein
thu
one
main
protein
featur
determin
accumul
main
focu
research
antigen
target
proteasom
via
ubiquitindepend
mechan
thought
provid
antigen
process
present
complex
mhci
enhanc
antigenspecif
ctlrespons
direct
achiev
clone
ubencod
sequenc
onto
target
gene
ad
destabil
ntermin
residu
ub
make
antigen
better
proteasom
substrat
cell
ub
cleav
posttransl
modif
chimer
protein
catalyz
ctermin
ubiquitin
hydrolas
thu
expos
ndegron
nef
modifi
way
gener
ubargnef
led
improv
immunogen
nef
mice
fusion
ubiquitin
use
immun
gene
express
librari
orf
open
read
frame
encod
plasmid
modifi
addit
ubiquitin
encod
sequenc
singl
immun
use
gene
gun
librari
stimul
strong
tcell
respons
antigen
respons
regist
enhanc
ctlactiv
product
tcell
hlatetram
bind
addit
ubiquitin
nterminu
synthet
protein
consist
hiv
ctlepitop
also
result
increas
immunogen
prototyp
dnavaccin
incorrect
protein
fold
also
act
proteasom
degrad
signal
use
increas
immunogen
influenza
viru
protein
unstabl
variant
construct
disrupt
alphahel
region
via
introduct
short
foreign
amino
acid
sequenc
immun
gene
destructur
result
much
stronger
ctlrespons
induc
origin
gene
howev
viral
protein
fusion
proteasometarget
signal
result
increas
degrad
gag
protein
modifi
ubiquitin
destabil
ntermin
arginin
residu
ubrgag
show
slight
increas
degrad
rate
effect
destabil
protein
requir
insert
addit
expos
lysin
residu
ek
ubrekgag
ubrekgag
chimera
effect
direct
proteasom
increas
present
mhciantigen
peptid
complex
cell
surfac
howev
significantli
increas
antigag
ctlrespons
mous
immun
also
enhanc
immunogen
perform
observ
similar
modif
dnaimmunogen
express
nucleocapsid
core
protein
hepat
c
viru
hcv
hcv
core
gene
carri
cleavabl
well
uncleav
ubiquitin
residu
nstabil
ndestabil
amino
acid
residu
equal
poor
immunogen
viral
model
describ
increas
proteasom
degrad
result
increas
protect
immun
notabl
protein
requir
ubiquitin
degrad
first
protein
discov
ornithin
decarboxylas
odc
degrad
atpand
antizymeproteindepend
cterminu
antizym
bind
ntermin
region
odc
direct
proteasom
antizym
releas
addit
antizymebind
site
nterminu
odc
contain
also
ctermin
pestsign
experi
delet
mutant
odc
shown
minim
signal
requir
rapid
degrad
odc
proteasom
ctermin
stretch
amino
acid
demonstr
region
requir
bind
odc
proteasom
ubiquitinconjug
system
multistag
mechan
complex
regul
use
protein
degrada
tion
signal
direct
protein
proteasom
via
ubiquitinindepend
mechan
circumv
effect
multitud
factor
thu
provid
straightforward
way
proteasom
target
fusion
revers
transcriptas
minim
proteasometarget
signal
odc
repres
two
short
amino
acid
sequenc
odc
cterminu
led
acceler
degrad
increas
immunogen
chimer
gene
mice
compar
origin
gene
modif
also
success
appli
weakli
immunogen
revers
transcriptas
drugresist
help
enhanc
cellular
antibodi
immun
respons
mutant
enzym
form
process
antigen
via
pathway
involv
endoplasm
reticulum
er
increas
antigen
affin
toward
er
improv
immunogen
perform
antigen
protein
calreticulin
crt
abund
er
associ
compon
involv
present
antigen
via
pathway
fusion
calreticulin
tumor
antigen
use
improv
tcell
immun
respons
tumor
cell
dnavaccin
encod
fusion
crt
protein
human
papilloma
viru
creat
mice
immun
dnaimmunogen
exhibit
signific
increas
popul
tcell
lytic
activ
tumor
fusionprotein
crt
anoth
protein
also
improv
antigenspecif
tcell
immun
respons
mice
alter
local
protein
associ
increas
affin
er
also
achiev
differ
strategi
involv
antigen
fusion
extracellular
domain
fmslike
tyrosin
kinas
ligand
fl
gene
fusion
introduc
subcutan
gene
gun
techniqu
led
consider
increas
capac
activ
specif
tcell
compar
unmodifi
gene
vitro
studi
show
cell
line
transfect
dna
present
antigen
complex
mhc
class
molecul
effect
cell
transfect
origin
gene
chimera
potent
activ
tcell
antitumor
effect
depend
anoth
success
case
enhanc
immun
respons
manipul
ersign
report
envelop
protein
hepat
c
viru
effect
achiev
duplic
erloc
sequenc
promot
accumul
subsequ
releas
endoplasm
reticulum
peptid
bound
mhcii
mainli
exogen
origin
captur
endocytosi
direct
lysosom
fig
howev
demonstr
intracellular
protein
present
mhcii
result
autophagi
protein
transport
lysosom
via
chaperonemedi
transfer
carri
transportprotein
engulf
cytoplasm
lysosom
membran
format
doublemembran
autophagosom
transport
lysosom
antigen
cleav
acid
proteas
result
peptid
load
onto
mhcii
molecul
brought
cell
surfac
cell
surfac
complex
recogn
tcell
receptor
lead
stimul
cellular
humor
immun
clinic
trial
also
shown
current
gener
dnavaccin
induc
strong
antibodi
respons
therefor
target
antigen
present
mhcii
pathway
order
activ
seem
especi
advantag
target
achiev
artifici
supplement
immunogen
lysosom
local
signal
dnaantigen
specif
direct
lysosom
use
protein
sort
signal
intracellular
sort
signal
found
cytoplasmtermin
region
transmembran
lysosomeassoci
protein
short
amino
acid
sequenc
divid
tyrosineand
dileucinebear
sequenc
tyrosinebear
signal
consensu
motif
npxi
x
amino
acid
amino
acid
larg
hydrophob
sidechain
consensu
sequenc
dileucin
signal
de
xxxl
li
dxxll
signal
recogn
adaptor
protein
ap
relat
complex
direct
transgolgi
plasmat
membran
endosom
motif
cluster
acid
amino
acid
npfsd
sequenc
number
cellular
protein
direct
lysosom
due
presenc
phosphoryl
mannos
residu
attach
consensu
sequenc
nx
st
also
signal
seem
direct
cytoplasm
protein
lysosom
via
autophagosom
mechan
shown
tyrosineand
dileucin
signal
effect
direct
heterolog
protein
lysosom
activ
use
signal
target
mhcii
present
lysosomeassoci
membran
protein
invari
chain
ii
motif
lysosom
protein
limp
ii
sort
signal
lysosomeassoci
protein
target
antigen
process
via
mhcii
present
pathway
enhanc
present
shown
vitro
experi
mous
immun
experi
demonstr
chimera
induc
stronger
lymphoprolif
activ
ctlactiv
higher
antibodi
titer
compar
nonmodifi
dnaimmunogen
increas
immun
respons
respons
fusion
shown
immun
dna
encod
fusion
lampgag
dnavaccin
stimul
prolong
b
tcell
respons
immun
respons
caus
inject
nonmodifi
gag
gene
rapidli
reced
anoth
success
redirect
cytoplasm
protein
nucleocapsid
protein
coronaviru
sar
sarsn
immun
mice
dna
encod
chimera
led
balanc
specif
product
strong
ctlrespons
sarsn
also
fusion
revers
transcriptas
improv
immunogen
prototyp
dnavaccin
drugresist
viru
strong
immun
respons
mix
rais
wild
drugresist
revers
transcriptas
circumv
toler
immun
system
toward
conserv
retrovir
antigen
fusion
increas
immunogen
dna
immunogen
encod
flaviviru
envelop
protein
candid
vaccin
dengu
viru
type
base
dna
encod
premembran
prem
envelop
e
transmembran
cytoplasm
domain
e
replac
similar
domain
chimera
exhibit
characterist
granular
cytoplasm
stain
indic
coloc
endogen
mhcii
protein
observ
case
nonmodifi
antigen
mice
immun
gene
chimera
exhibit
much
higher
level
neutral
antibodi
control
receiv
parent
preme
gene
similar
prototyp
dnavaccin
design
west
nile
viru
case
premembran
envelop
wn
preme
code
sequenc
fuse
sequenc
encod
transmembran
cytoplasm
domain
mice
immun
gene
wn
chimera
respond
longlast
product
high
titer
neutral
antibodi
dna
encod
origin
antigen
induc
shortterm
lowtit
antibodi
respons
altogeth
result
provid
basi
creat
panel
effect
dnavaccin
flavivirus
introduct
protein
gene
fuse
sequenc
encod
also
increas
immun
respons
introduct
secretori
variant
form
dnachimer
recombin
viru
induc
strong
antitumor
immun
respons
prevent
format
tumor
reduc
size
review
one
alreadi
present
howev
unsuccess
case
appli
modif
cytoplasm
protein
case
nucleocapsid
protein
hcv
plasmid
construct
express
chimer
fusion
protein
hcv
nuclecapsid
protein
signaland
ctermin
sequenc
immun
mice
construct
lead
detect
antibodi
respons
cell
prolifer
induc
weak
ctlactiv
thu
direct
lysosom
fuse
immunogen
necessarili
ensur
enhanc
type
immun
respons
mhcii
molecul
requir
transport
lysosom
compart
transport
involv
invari
chain
mhc
class
ii
molecul
ii
two
sort
signal
found
cytoplasm
domain
ii
shown
endogen
synthes
protein
normal
present
via
mhcii
pathway
effect
present
mhcii
fuse
ii
numer
experi
anim
model
demonstr
fusion
recombin
antigen
ii
enhanc
broaden
prolong
protect
immun
respons
result
chimer
dnavaccin
vitro
vivo
experi
shown
immunogen
base
adenoviru
express
fusion
ii
glycoprotein
lymphocyt
choriomening
viru
lcmv
increas
abil
stimul
lcmvspecif
tcell
moreov
mice
immun
plasmid
resist
infect
lethal
lcmv
dose
approach
also
effect
immun
larger
speci
dnaconstruct
made
encod
major
surfac
protein
anaplasma
marginal
fuse
lysosometarget
motif
bovin
ii
direct
chimera
lysosom
compart
singl
dose
plasmid
effect
stimul
immun
respons
seen
potent
prolifer
tcell
product
specif
igg
singl
inject
construct
induc
antigen
specif
memori
cell
form
basi
acceler
respons
repeat
dose
antigen
precis
mechan
behind
autophagi
yet
unknown
despit
intens
ongo
studi
regard
antigen
retarget
shown
fusion
autophagosomeassoci
protein
influenza
viru
matrix
protein
lead
consider
increas
mhc
class
ii
present
respons
tcell
confirm
autophagi
constantli
effect
direct
cytoplasm
protein
present
via
mhc
class
ii
pathway
use
stimul
respons
effect
approach
induct
thelper
immun
respons
target
protein
secret
extracellular
environ
fusion
gag
e
protein
secretori
chemokin
direct
viral
protein
secretori
pathway
chimer
gene
induc
effect
product
antibodi
macaqu
macaqu
immun
chimera
infect
pathogen
lower
viral
load
infect
anim
exampl
convers
endogen
antigen
exogen
captur
endocytosi
transfer
lysosom
pathway
well
endogen
lysosom
target
enhanc
antigen
present
complex
mhc
class
ii
molecul
consider
increas
immunogen
dnavaccin
today
mankind
face
acut
problem
creat
vaccin
hazard
diseas
hepat
c
immunodefici
caus
cancer
dnavaccin
technolog
open
wide
rang
possibl
creat
effect
vaccin
one
immunogen
target
paper
review
number
signal
sequenc
introduc
immunogen
direct
predetermin
process
present
pathway
usual
differ
one
would
natur
take
direct
antigen
mhci
present
pathway
would
enhanc
cytotox
respons
direct
onto
mhcii
pathway
would
activ
thelper
cell
stimul
cellular
humor
respons
overal
use
signal
sequenc
control
guid
immunogen
present
increas
immunogen
potenti
exist
dnaimmunogen
help
creat
new
effect
prophylact
therapeut
vaccin
divers
human
applic
